SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eris Lifesciences informs about analyst call

16 Aug 2017 Evaluate

Eris Lifesciences has informed about the updation in the letter dated 14th August, 2017 regarding schedule of Analyst and Investor call pursuant to SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

1391.30 4.55 (0.33%)
11-May-2026 12:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1875.00
Dr. Reddys Lab 1296.40
Cipla 1314.45
Zydus Lifesciences 943.65
Lupin 2268.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×